This shot could prevent HIV. Here's how to get it in Arizona

Yeztugo, a twice-yearly shot, could be the catalyst for stopping a recent spike in new HIV diagnoses. It's now available in Arizona. How to get it.
Bay Area Reporter

New biannual PrEP injectable option rolls out in SF

Patients are already receiving the new PrEP injectable option lenacapavir in the Bay Area, though issues with insurance are complicating the process of getting shots. The new injectable was approved ...
AOL

‘Transformative’ HIV PrEP shot slowly overcomes cost hurdles

HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but these celebrations were tempered by insurers’ reluctance to cover its ...
Nasdaq

Yeztugo® (Lenacapavir) Is Now the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo® (lenacapavir)—the company’s ...
NBC Chicago

FDA approves powerful HIV drug that nearly eliminated spread in clinical trials

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...
Newsday

Game changer: HIV transmission nearly eliminated by twice-a-year injectable drug — at a $28G annual cost

A twice yearly injection that is highly effective in preventing HIV transmission could dramatically reduce infections and save lives — if the people who would most benefit from the drug can obtain it, ...
The Baltimore Sun

Howard is among few places in Maryland offering a new shot to prevent HIV

The Howard County Health Department is now among just a handful of Maryland health agencies that offer a twice-yearly HIV injection. Howard County will dispense the biannual prevention injection ...
NBC New York

FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option

The Food and Drug Administration on Wednesday approved Gilead's twice-yearly antiviral injection for preventing HIV — a milestone that the company and some experts say could help bring the world ...
STAT

HIV protection with just two shots a year: FDA approves Gilead drug

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Ed’s stories explore prescription drug ...

Use of Gilead's HIV prevention shot rises, but US insurance gaps remain

By Deena Beasley May 5 (Reuters) - Use of Gilead Sciences' Yeztugo, a twice-yearly injection to prevent HIV infection, has climbed since its June launch, but U.S. health providers say not all patients ...